Pulmonary Hypertension PBMC
About: Pulmonary Hypertension PBMC samples are collected from clinically confirmed pulmonary hypertension donors and cryopreserved. These PBMCs are ideal for investigating immune dysregulation, inflammatory cytokine production, and gene expression profiles in pulmonary hypertension pathogenesis.
| Lot Number | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 73154 | Pulmonary Hypertension | 10M | Caucasian | 74 | Female |
Adempas 2.5mg TID Letairis 10mg QD Uppradi 1600mcg BID Omeprazole 20mg QD Rosuvastatin 10mg QD Cholestipol 2 1mg tablets QD Vitamin b12, D, calcium supplements
|
1 | |||
| 59295 | Pulmonary Hypertension | 5M | African American | 45 | Female |
Plaque-nil 200mg QD IViG Infusions every 3 weeks Lyrica 200mg QD OxyContin 20mg QD Oxycodone 10.325mg QD
|
4 | $765.00 | ||
| 69946 | Pulmonary Hypertension | 50M | Hispanic/Latino | 42 | Female | United States (US) |
Orenitram 5mg Letairis 10 mg Adcirca 20 mg
|
92 | $1,208.00 | |
| 69059 | Pulmonary Hypertension | 50M | Hispanic/Latino | 41 | Female | United States (US) |
Orenitram 0.5 mg 3x/day Letairis 10 mg/1x day Winrevair 1mg/3 weeks, last injection 5/11 Bumex as needed
|
82 | $1,208.00 | |
| 66907 | Pulmonary Hypertension | 50M | Hispanic/Latino | 43 | Female | United States (US) |
Letairis 10 mg 1x/day Adempas 2.5 mg 3x/day Winrevair 1.3 ml/ every 3 weeks, last injection 5/13/25
|
115 | $1,208.00 | |
| 68412 | Pulmonary Hypertension | 50M | Asian/Pacific Islander | 58 | Female | United States (US) |
TYVASO - NEBULIZER BOSENTAN 125 MG- PAH BABY ASPRIN ALDATONE 5 MG MUTLTI VIT
|
84 | $1,208.00 | |
| 55948 | Pulmonary Hypertension | 9M | Caucasian | 70 | Female | United States (US) |
Sildenafil 20mg TID lisinopril 5mg Hydroxychloroquine 200 mg BID pepcid Tylenol PRN O2
|
2 |
High-Quality Pulmonary Hypertension PBMC for Research
Pulmonary Hypertension Human PBMC products are sourced from donors clinically diagnosed with Pulmonary Hypertension and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, inflammatory cytokine production, and gene expression profiles in pulmonary hypertension pathogenesis
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed pulmonary hypertension donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified pulmonary hypertension diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional pulmonary hypertension-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in pulmonary hypertension pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Pulmonary Hypertension PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – with the exception of GMP leukopaks, all our products are research use only (RUO).
1 Answer
Our complete catalog can be found here: https://sanguinebio.com/products/
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective colleciton services to tailored to fit your research. For more information and request a quote, please see: https://sanguinebio.com/prospective-biospecimen-collection-services/
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory which can be found here https://sanguinebio.com/products/?pro_inventory=inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: https://sanguinebio.com/quality-and-compliance/
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.